Journal article
Angiostatin Generation by Human Pancreatic Cancer
The Journal of surgical research, v 77(1), pp 55-58
Jun 1998
PMID: 9698533
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Background.Angiostatin, a proteolytic fragment of plasminogen, is a potent inhibitor of angiogenesis.In vitro,angiostatin can be generated by pancreatic elastase proteolysis of plasminogen; however,in vivo,the enzymes responsible for angiostatin production are not known. A recent study demonstrates the involvement of a serine protease in angiostatin generation. In this study we sought to determine if the human pancreatic carcinoma cell line ASPC1 produced enzymatic activity capable of converting plasminogen to angiostatin and to determine if urokinase plasminogen activator (uPA) is involved in this system.
Methods.ASPC1 cells were grown to near confluence in 20% FBS-RPMI. Media were changed to serum free and cells cultured for an additional 24 h. The serum free conditioned media (SFCM) was obtained. Angiostatin generation was determined by incubating 20 μg of human plasminogen with 100 μl of SFCM for 0, 3, 8, 12, 24, and 48 h. Plasminogen cleavage was assessed in the presence of the following protease inhibitors: pefabloc, aprotinin, phosphoramidon, leupeptin, and EDTA. The effect of uPA on angiostatin generation was determined by incubating plasminogen with antibody to uPA. Angiostatin generation was determined by Western blot.
Results.Incubation of plasminogen with SFCM resulted in the generation of immunoreactive bands at 48 kDa corresponding to human angiostatin. Angiostatin generation by ASPC1 SFCM was time dependent; there was a significant decrease in the plasminogen substrate beginning at 3 h with complete conversion to angiostatin by 48 h. Enzymatic activity leading to angiostatin production was found to be due to a serine protease. Antibody to uPA effectively blocked angiostatin production by ASPC1 SFCM in a dose-dependent manner.
Conclusion.Human pancreatic cancer cells express enzymatic activity which leads to the generation of angiostatin. Conversion of plasminogen to angiostatin is due to a serine protease. This serine protease is most likely uPA.
Metrics
Details
- Title
- Angiostatin Generation by Human Pancreatic Cancer
- Creators
- Christine A. O'Mahony - Allegheny University of the Health SciencesAmy Seidel - Allegheny University of the Health SciencesDaniel Albo - Allegheny University of the Health SciencesHong Chang - Allegheny University of the Health SciencesGeorge P. Tuszynski - Allegheny University of the Health SciencesDavid H. Berger - Allegheny University of the Health SciencesHsihui Chang - Accounting
- Publication Details
- The Journal of surgical research, v 77(1), pp 55-58
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Accounting
- Web of Science ID
- WOS:000075267500011
- Scopus ID
- 2-s2.0-0031880835
- Other Identifier
- 991019168864604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Surgery